Ann & Robert H. Lurie Children’s Hospital
This page includes a searchable index of all resources created by Ann & Robert H. Lurie Children’s Hospital and Northwestern University. If you would like to add a resource to this index, please contact us.
Building an Effective System of Care to Address Emerging Threats to Infants and Children
The page describes a project by the American Academy of Pediatrics and the CDC to help pediatricians deal with new health threats to children, like …
Ask aRCie
Preventing Hypothermia
This webpage explains how to prevent and treat hypothermia and frostbite during cold weather. It explains that hypothermia occurs when the body loses heat faster …
Public Access Defibrillation (PAD) State Law Fact Sheet
This fact sheet explains state laws about Public Access Defibrillation (PAD) programs, which aim to improve survival rates from out-of-hospital cardiac arrests. It highlights the …
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower RespiratoryTract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United Sta
This article discusses the use of Pfizer's RSV vaccine for pregnant women to protect infants from RSV-related lung disease. The CDC recommends giving the vaccine …
ACIP Evidence to Recommendations for Use of Nirsevimab in Children 8–19 Months of Age at Increased Risk of Severe Disease Entering Their Second RSV Season
This webpage provides evidence for the recommendations made by the Advisory Committee on Immunization Practices (ACIP) for the use of nirsevimab for a population of …
Vaccines For Children (VFC) Operations Guide
This guide explains how the Vaccines for Children (VFC) program works from July 2024 to June 2025. It describes who can get free vaccines, like …
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024
2024
· Centers for Disease Control and Prevention (CDC),
· U.S. Public Health Service,
· University of Rochester,
· University of Cincinnati,
· Cincinnati Children's Hospital Medical Center,
· Vanderbilt University,
· Texas Children's Hospital,
· Baylor College of Medicine,
· University of Washington,
· University of Pittsburgh,
· Children's Mercy Kansas City
This study looks at the impact of respiratory syncytial virus (RSV) in young children during the 2023-2024 season. It describes how two new RSV prevention …
Hazards During Wildland Fire Cleanup
This webpage describes the dangers and safety tips for cleaning up after wildfires. It warns about unstable structures, trees, carbon monoxide from machines, confined spaces, …
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
This article describes the use of nirsevimab, a new drug approved in 2023, to prevent severe respiratory syncytial virus (RSV) disease in infants and young …
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024
2024
· Centers for Disease Control and Prevention (CDC),
· Vanderbilt University,
· Seattle Children's Hospital,
· Baylor College of Medicine,
· University of Rochester
This study examines the effectiveness of nirsevimab, a monoclonal antibody, in preventing RSV-related hospitalizations in infants during their first RSV season. Conducted from October 2023 …